Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice
Halilbasic E, Fiorotto R, Fickert P, Marschall H, Moustafa T, Spirli C, Fuchsbichler A, Gumhold J, Silbert D, Zatloukal K, Langner C, Maitra U, Denk H, Hofmann AF, Strazzabosco M, Trauner M. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice. Hepatology 2009, 49: 1972-1981. PMID: 19475687, PMCID: PMC3569724, DOI: 10.1002/hep.22891.Peer-Reviewed Original ResearchConceptsNorursodeoxycholic acidBile duct unitsUnique physiologicSerum bile acid levelsDuct unitsBile acid levelsCholestatic liver diseaseDramatic therapeutic effectsTherapeutic propertiesRelative resistanceCholehepatic shuntingCholestatic injuryPharmacologic featuresLiver histologyLiver diseaseRole of CFTRBile compositionPharmacologic propertiesCholeretic effectNorUDCATherapeutic effectExpression of MRP4Standard dietSerum biochemistryExperimental cholestasis